Noticias financieras organizadas para conectar titulares, símbolos, fuente, fecha y sentimiento con tu análisis y operativa.
VEEV
Si escribes ticker, YENOM prioriza ese instrumento. Si lo dejas vacío puedes explorar el feed general o por tema.
finance.yahoo.comPOSITIVO
Veeva (VEEV) Stock May Be 11% Below Fair Value After Biotech Adoption News
Veeva Systems has delivered a mixed share price story over recent years, which puts the focus firmly on whether the current market value lines up with the cash it can generate. With the stock now back near the spotlight after a solid multi…
Veeva Summit to Showcase AI Innovations and the Leaders Transforming R&D and Quality
Eli Lilly and Company, Pfizer, Sanofi, UCB, and more share learnings speeding drug development, connecting trials, and modernizing quality and manufacturing PLEASANTON, Calif., Oct. 8, 2026 /PRNewswire/ -- At Veeva R&D and Quality Summit o…
Is Invesco S&P 500 Equal Weight ETF (RSP) a Strong ETF Right Now?
Designed to provide broad exposure to the Style Box - Large Cap Blend category of the market, the Invesco S&P 500 Equal Weight ETF (RSP) is a smart beta exchange traded fund launched on 04/24/2003. What Are Smart Beta ETFs? Products that a…
Why Is Veeva Systems (VEEV) Drawing Attention After Reaching 175 Biotechs?
Veeva Systems (NYSE:VEEV) reported that more than 175 emerging biotech companies now use its Veeva Basics platform for drug development. The firm said its Data Quality System has processed and cleaned information for over 1 million subject…
Jim Cramer Has Reservations About One of These Software Comebacks
On October 1, Jim Cramer discussed Veeva Systems Inc. (NYSE:VEEV) while reviewing the third-quarter recovery in software stocks. He mentioned that he prefers Salesforce, Inc. (NYSE:CRM), as he said: On the first day of a brand new quarter,…
Veeva's DQS Scales Data Automation Across 1,000+ Clinical Studies
Veeva Systems VEEV continues to strengthen its position in the life sciences software market as its Veeva DQS (Data Quality System) platform expands its reach across clinical trials. The company said that the solution has now supported dat…
Emerging Biotechs Standardize on Veeva Basics to Accelerate Drug Development
More than 175 biotechs use pre-configured applications to streamline operations PLEASANTON, Calif., Oct. 7, 2026 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced that more than 175 emerging biotechs are establishing a technology…
Veeva DQS Cleans Data for More Than 1 Million Subjects Across Over 1,000 Studies
Automates data reconciliation, saving clinical teams significant cost, time, and effort PLEASANTON, Calif., Oct. 6, 2026 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced that Veeva DQS (Data Quality System) has aggregated and cle…
Veeva's OpenData to Help Servier Build a Global AI Data Foundation
Veeva Systems VEEV recently announced that Servier has selected Veeva OpenData to standardize customer reference data across more than 80 countries. The move strengthens Veeva's position as a key provider of data solutions for global life…
Should You Invest in the Invesco S&P 500 Equal Weight Health Care ETF (RSPH)?
Looking for broad exposure to the Healthcare - Broad segment of the equity market? You should consider the Invesco S&P 500 Equal Weight Health Care ETF (RSPH), a passively managed exchange traded fund launched on November 1, 2006. Passivel…
NIKE, Inc. (NKE) shares fell 3.6% after the company reported fourth-quarter fiscal 2026 revenues of $11.21 billion, missing the Zacks Consensus Estimate by 1.65%. Synaptics Incorporated (SYNA) shares surged 14.1% after ON Semiconductor (ON…
13 High-Conviction & Catalyst-Driven Long Ideas for 4Q 2026
Investing.com -- Wells Fargo Securities named 13 stocks across seven sectors as its fourth-quarter 2026 long ideas, citing company-specific catalysts that could drive significant gains. Before you buy NVIDIA: our AI model's stock picks are…
Veeva Systems (VEEV) Stock Sinks As Market Gains: What You Should Know
Veeva Systems (VEEV) closed at $273.25 in the latest trading session, marking a -3.08% move from the prior day. The stock's change was less than the S&P 500's daily gain of 0.73%. On the other hand, the Dow registered a gain of 0.49%, and…
Veeva Systems (VEEV) Stock Declines While Market Improves: Some Information for Investors
In the latest close session, Veeva Systems (VEEV) was down 1.23% at $281.93. This move lagged the S&P 500's daily gain of 0.2%. Meanwhile, the Dow experienced a rise of 0.04%, and the technology-dominated Nasdaq saw an increase of 0.04%. T…
AI Will Revolutionize Medicine. This Company Provides the Plumbing.
Veeva Systems is making that transformation happen. The Pleasanton, Calif.–based company develops software for biotechnology and pharmaceutical customers to manage everything from research and development and regulatory submissions to day-…
Veeva Systems Inc. (VEEV) Is a Trending Stock: Facts to Know Before Betting on It
Veeva Systems (VEEV) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock. Shares of this provider of cloud-based…
Servier Adopts Veeva OpenData Globally to Scale AI
Establishing an AI-ready data foundation in more than 80 countries PLEASANTON, Calif., Sept. 30, 2026 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced that Servier is standardizing customer reference data across more than 80 coun…
Should Invesco S&P 500 Equal Weight ETF (RSP) Be on Your Investing Radar?
Designed to provide broad exposure to the Large Cap Blend segment of the US equity market, the Invesco S&P 500 Equal Weight ETF (RSP) is a passively managed exchange traded fund launched on April 24, 2003. The fund is sponsored by Invesco.…
Brokers Suggest Investing in Veeva (VEEV): Read This Before Placing a Bet
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect…
Notable healthcare headlines for the week: Eli Lilly, Novo Nordisk, and Centene in focus
Wall Street closed higher Friday as easing Treasury yields and lower oil prices supported equities, with investors continuing to monitor developments surrounding the Strait of Hormuz. The blue-chip Dow (DJI [https://seekingalpha.com/symbol…
[Aerial View of a Fog-Filled, Pacific Northwest Landscape Near Portland, Oregon] Velvetfish/iStock via Getty Images Goldman Sachs says investors should focus on stocks where they see a differentiated view on long-term revenue growth as val…
Veeva Systems (VEEV) Outperforms Broader Market: What You Need to Know
Veeva Systems (VEEV) closed the most recent trading day at $280.68, moving +2.12% from the previous trading session. The stock exceeded the S&P 500, which registered a gain of 0.51% for the day. At the same time, the Dow added 0.93%, and t…
Veeva Unveils AI Study Builder Agent to Speed Clinical Trial Setup
Veeva Systems VEEV recently introduced Veeva Study Builder Agent, a new AI-powered solution designed to accelerate clinical study configuration within its Clinical Data platform. The launch reinforces Veeva's push to embed AI across its li…
Veeva (VEEV) Down 2.6% Since Last Earnings Report: Can It Rebound?
A month has gone by since the last earnings report for Veeva Systems (VEEV). Shares have lost about 2.6% in that time frame, underperforming the S&P 500. Will the recent negative trend continue leading up to its next earnings release, or i…
How Investors Are Reacting To Veeva Systems (VEEV) Expanding Agentic AI And Winning New Pharma Clients
In recent days, Veeva Systems has rolled out new AI-powered tools such as Veeva Study Builder Agent and Veeva Falcon Router, while announcing major customer wins including Oxford Biomedica adopting Veeva Quality Cloud and Amgen planning a…
Veeva Systems (VEEV) Could Be 29% Undervalued Following Its New AI Study Design Launch
Veeva Systems launches new AI study design agent Veeva Systems (VEEV) has unveiled Veeva Study Builder Agent, an AI tool that configures its EDC and Data Quality System directly from a clinical study protocol, aiming to streamline and stan…
New Veeva Study Builder Agent to Configure Clinical Studies in as Little as One Day
Standards-first agent delivers faster and more consistent EDC and DQS builds PLEASANTON, Calif., Sept. 24, 2026 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced Veeva Study Builder Agent, a new AI solution that configures Veeva E…
Quality Management System Software Market Forecasts Growth from $11.73B (2026) to $20.43B by 2031, Profiling Veeva Systems, Siemens, PTC, SAP, Oracle & 15 Others
Company Logo The global Quality Management System (QMS) software market is projected to grow from USD 11.73 billion in 2026 to USD 20.43 billion by 2031, at an 11.7% CAGR. Growth is driven by cloud-based QMS platforms, AI-powered quality a…
Veeva Unveils Falcon Router to Streamline Biopharma Case Routing
Veeva Systems VEEV recently expanded its AI strategy with the launch of Falcon Router, a new agentic solution designed to help biopharma companies streamline the intake and routing of safety, quality and medical cases across reporting chan…
Vault CRM Extends Market Leadershipas Another Top 20 Biopharma Chooses Veeva
With 190 live customers and 14 top 20 biopharma commitments, Vault CRM is the fastest path to AI PLEASANTON, Calif., Sept. 23, 2026 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced a new top 20 biopharma commitment, adding to rec…
eClinical Solutions Market by Product, Application, Trial Phase, End User, Regulatory, AI, Growth, Market Size - Forecast to 2030
Company Logo The global eClinical solutions market is projected to grow from USD 13.18 billion in 2025 to USD 25.22 billion by 2030, registering a 13.9% CAGR. Growth is driven by rising clinical trial costs, regulatory requirements, R&D in…
Pharmacovigilance Software Market Size, Share & Trends Analysis - Global Opportunity Analysis and Industry Forecast (2026-2036)
Company Logo The global pharmacovigilance software market is projected to grow from USD 4.5 billion in 2026 to USD 12.7 billion by 2036, at a 10.9% CAGR. Growth is driven by stricter drug safety regulations, expanding clinical trials, risi…
Here's How Much a $1000 Investment in Veeva Systems Made 10 Years Ago Would Be Worth Today
For most investors, how much a stock's price changes over time is important. Not only can it impact your investment portfolio, but it can also help you compare investment results across sectors and industries. Another thing that can drive…
Veeva Expands Amgen Partnership With Global Vault CRM Rollout Plan
Veeva Systems VEEV recently announced that Amgen AMGN has selected its Vault CRM for a global deployment, extending a collaboration that has spanned more than a decade. The rollout is expected to support Amgen's commercial operations as it…
2 Growth Stocks to Add to Your Roster and 1 Facing Headwinds
2 Growth Stocks to Add to Your Roster and 1 Facing Headwinds Growth boosts valuation multiples, but it doesn't always last forever. Companies that cannot maintain it are often penalized with large declines in market value, a lesson ingrain…